SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001415889-16-005054
Filing Date
2016-03-14
Accepted
2016-03-14 10:27:07
Documents
109

Document Format Files

Seq Description Document Type Size
1 FORM S-1 vstas1_mar2016.htm S-1 4587092
2 ex23-1.htm EX-23.1 3354
3 logo.jpg GRAPHIC 8562
  Complete submission text file 0001415889-16-005054.txt   14223256

Data Files

Seq Description Document Type Size
4 vsta-20151231.xml EX-101.INS 2964725
5 vsta-20151231.xsd EX-101.SCH 104839
6 vsta-20151231_cal.xml EX-101.CAL 66861
7 vsta-20151231_def.xml EX-101.DEF 454633
8 vsta-20151231_lab.xml EX-101.LAB 509237
9 vsta-20151231_pre.xml EX-101.PRE 587731
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: S-1 | Act: 33 | File No.: 333-210152 | Film No.: 161502771
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences